Global X-Ray Detectors Market to Surpass USD 4.5 Billion Due to Increasing Use of CT Scans for COVID-19 Diagnosis
By LabMedica International staff writers Posted on 19 Oct 2021 |

The global X-ray detectors market is projected to expand at a CAGR of 5.9% during the forecast period of 2021-2031 to reach USD 4.6 billion by 2031, driven mainly by the rising use of radiographic chest scans for COVID-19 diagnosis.
These are the latest findings of Transparency Market Research (Albany, NY, USA), a next-generation market intelligence provider. The market growth will be further aided by the increasing use of X-ray detectors in several applications, growing incidences of gastrointestinal, cardiovascular, oral, and genitourinary disorders and introduction of innovative X-ray detectors for security, industrial, medical, dental, veterinary, and other purposes. In addition, technological advancements that will enable detectors to provide better detail, higher resolution, and decreased exposure will also provide a boost to the global X-ray detectors market.
The use of X-ray detectors for COVID-19 diagnosis will prove to be a key contributor to market growth. Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests are accurate in detecting COVID-19 in individuals, but are very complicated, time-consuming, and costly. Stakeholders in the X-ray detectors market are taking advantage of this opportunity to increase the availability of radiological examination through X-ray such as CT (Computed Tomography) scans, which is a cost-efficient and easily available option. The rising use of X-ray detectors for radiographic chest scans during the COVID-19 pandemic offers substantial growth opportunities.
These detectors are also being optimized by the players for various industrial inspection and material sorting applications. In addition, wider application of X-ray detectors in image-guided radiation therapy, fluoroscopy, digital radiography, cone beam CT, digital tomosynthesis, and others are expected to further fuel market growth. The growing focus of several countries on developing a well-established healthcare infrastructure is also likely to drive the growth of the global X-ray detectors market.
Flat panel detectors are expected to observe a rise in demand, as they offer various advantages such as uniform imaging quality, less image distortion, low time consumption, good reproducibility, and better patient condition access, among others. In addition, they are proven to be very successful in high exposure interventional procedures. Among panel types, the large panel category of the X-ray detectors market is expected to witness promising growth. The growing number of patients undergoing diagnostic imaging tests, and expanding adoption of new and advanced large panel detectors are likely to propel the growth of the X-ray detectors market.
Geographically, North America held the largest share of the global X-ray detectors market in 2020 and is expected to maintain its position during the forecast period. The growing number of dental CBCT scans in the US due to increasing dental diseases among a considerable share of its population is anticipated to propel the growth of the North American X-ray detectors market. Furthermore, the Asia Pacific X-ray detectors market is also projected to grow rapidly during the forecast period. Increasing efforts by several countries in the region to develop a well-established healthcare infrastructure, coupled with novel product launches in China and Japan, are expected to fuel the growth of the X-ray detectors market in the Asia Pacific.
Related Links:
Transparency Market Research
Latest COVID-19 News
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Genetic-Based Tool Predicts Survival Outcomes of Pancreatic Cancer Patients
A tumor marker is a substance found in the body that may signal the presence of cancer. These substances, which can include proteins, genes, molecules, or other biological compounds, are either produced... Read more
Urine Test Diagnoses Early-Stage Prostate Cancer
Prostate cancer is one of the leading causes of death among men worldwide. A major challenge in diagnosing the disease is the absence of reliable biomarkers that can detect early-stage tumors.... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more